Latest Financing News

Southern Palladium fast-tracks development at its Bengwenyama PGM Project, advancing drilling and infrastructure plans while securing key regulatory approvals.

Basin Energy has agreed to sell its Marshall Uranium Project to Green Canada Corporation, securing cash, shares, and a significant equity stake while retaining strategic rights and exposure to Canadian uranium assets.

Nufarm Finance (NZ) Limited reported a modest 1.1% rise in net profit to $20.53 million for the year ended September 2025, alongside increased distributions to security holders and maintained strong liquidity backed by its parent company.

Verbrec Limited has reported a strong FY2025 with record margins and resumed dividend payments after more than a decade, alongside strategic moves including a key acquisition and divestment.

Northern Minerals has applied to defer its 2025 AGM as it awaits regulatory review over potential foreign investment breaches, underscoring heightened scrutiny on shareholder compliance.

Earlypay Limited has extended its on-market share buy-back program for another 12 months, allowing the company to repurchase up to 10% of its ordinary shares without shareholder approval.

VHM Limited launches a fully underwritten A$10.3 million placement and a $1 million share purchase plan to fund the Goschen rare earths project, supported by strategic government financing.

VHM Limited has launched a fully-underwritten A$10.3 million placement alongside a A$1 million Share Purchase Plan to advance its Goschen Rare Earths and Mineral Sands Project toward a Final Investment Decision in early 2026.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Autosports Group Limited reports record FY25 revenue and profit, while announcing a strategic acquisition of 10 Barry Bourke Motors dealerships in Victoria, signaling robust growth momentum into FY26.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Mastermyne’s FY2025 AGM reveals resilience amid sector headwinds, operational disruptions, and legal proceedings, while positioning for growth with new leadership and contracts.